2013;17(Suppl 1):S367-S373
inhibition of VMAT2 reduces available dopamine that can be released into the synaptic cleft, which can reduce the symptoms associated with dopamine hypersensitivity
Wasting syndrome Wasting syndrome, characterized by excessive weight loss, commonly accompanies other health conditions.25 Growth hormone treatments, such as secretagogues, are often used to counter the muscle loss that comes with wasting.26 5 It so happens that tesamorelin, our recommendation for achieving a leaner body composition, is primarily intended for people with HIV, a disease commonly associated with wasting syndrome.27 In studies, it has successfully increased skeletal muscle area and density in HIV patients.28 Excess fat With growth hormone secretagogues, you get the added benefit of fat loss, as growth hormone can break down fat cells.29 Thats good news if your fitness goals involve achieving a more defined body
Just as excess T3 can have a bone-wasting effect, a combination T4/T3 medication may also compromise bone mineral density
9,11 MRP2 also exports some conjugated bile salts (especially dianionic forms, such as glucuronidated or sulfated bile acids) into bile at the canalicular membrane
